Zelira Therapeutics Ltd Is A Global Biopharmaceutical Company Focused On Cannabinoid Based Medicinesit Is Publicly Listed On The Asx Under The Code Zld And On The Otc As Zldafthe Company Is Dedicated To The Clinical Researchdevelopmentand Commercialization Of Therapeutic Cannabis Products Aimed At Treating Conditions Such As Autisminsomniaand Chronic Pain Zelira Operates In Both Australia And The U S Collaborating With Leading Institutions Like The Childrenae S Hospital Of Philadelphia And Curtin Universityits Product Line Includes The Proprietary Hopeaformulationswhich Are Designed For Autism Spectrum Disorder And Are Available In Several U Sstatesthe Company Is Also Advancing A Clinical Pipeline That Includes Candidates For Insomnia And Chronic Pain Managementwith Laboratory Capabilities In Pennsylvania And Louisianazelira Is Expanding Its U Spresence Through Product Licensing And Aims To Enter International Markets
United States
